Genoa Ventures

10 Women Investors Betting Big On Synthetic Biology

10 Women Investors Betting Big On Synthetic Biology

Andrea VuturoMay 10, 2023

How Early-Stage Investors Can Prepare for an Uncertain Outlook

How Early-Stage Investors Can Prepare for an Uncertain Outlook

Jenny Rooke PhD, shares with Fortune how early-stage investors can best prepare for an uncertain future.

Genoa NewsJenny RookeMarch 14, 2023

BrightSpec Announces $18.4 Million Financing Round

BrightSpec Announces $18.4 Million Financing Round

BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today the closing of an $18.4 million Series C financing round, led by Genoa Ventures and Arboretum Ventures.

Genoa NewsJenny RookeDecember 15, 2022

Genoa Ventures Again Named to Inc.’s Annual List of Founder-Friendly Investors - 2022

Genoa Ventures Again Named to Inc.’s Annual List of Founder-Friendly Investors - 2022

Genoa NewsAndrea VuturoOctober 7, 2022

Jenny Rooke featured in Vator News

Genoa NewsGuest UserSeptember 12, 2022

Bond Pet Food raises Series A to "Brew Meat"

Bond Pet Food raises Series A to "Brew Meat"

Genoa NewsGuest UserSeptember 12, 2022

Genoa Ventures Closes Second Fund, at $84M

Genoa Ventures Closes Second Fund, at $84M

Genoa NewsAndrea VuturoAugust 3, 2022

Jenny Rooke's Journey is an Inspiration for New Managers

Jenny Rooke's Journey is an Inspiration for New Managers

Genoa NewsAndrea VuturoAugust 3, 2022

Life Sciences Investor Genoa Ventures Raises $84 Million Second Fund

Life Sciences Investor Genoa Ventures Raises $84 Million Second Fund

Genoa NewsAndrea VuturoAugust 3, 2022

VC raises $84M fund to back agbio, foodbio and other non-drug biotechs

VC raises $84M fund to back agbio, foodbio and other non-drug biotechs

Genoa NewsAndrea VuturoAugust 3, 2022

Genoa Targets Nexus of Biology and Technology with New Fund

Genoa Targets Nexus of Biology and Technology with New Fund

Genoa NewsAndrea VuturoAugust 3, 2022

Genoa Ventures Announces Second Fund to Expand Investing in the Convergence of Biology and Technology

Genoa Ventures Announces Second Fund to Expand Investing in the Convergence of Biology and Technology

Genoa NewsAndrea VuturoAugust 2, 2022

New roles in Genoa Ventures as the firm continues to grow.

New roles in Genoa Ventures as the firm continues to grow.

Genoa NewsAndrea VuturoMay 16, 2022

Jenny Rooke & the VC Climate

Jenny Rooke & the VC Climate

Genoa NewsAndrea VuturoMay 12, 2022

Meiogenix Announces $13 Million series A financing round

Meiogenix Announces $13 Million series A financing round

Portfolio NewsAndrea VuturoMay 4, 2022

Codetta Biosciences Announces $15 Million in Series A Financing

Codetta Biosciences Announces $15 Million in Series A Financing

Portfolio NewsAndrea VuturoMay 4, 2022

Genoa Partner Vikram Chaudhery shares his insights into life science company scale-up and growth.

Genoa Partner Vikram Chaudhery shares his insights into life science company scale-up and growth.

Genoa NewsAndrea VuturoMay 4, 2022

Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System

Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System

Portfolio NewsAndrea VuturoFebruary 21, 2022

SimBioSys Raises $15 Million Series A to Develop the Future of Precision Cancer Care

SimBioSys Raises $15 Million Series A to Develop the Future of Precision Cancer Care

Portfolio NewsAndrea VuturoFebruary 21, 2022

Genoa’s Jenny Rooke Recognized by San Francisco Business Times as One of the Most Influential Women in Business of 2021

Genoa’s Jenny Rooke Recognized by San Francisco Business Times as One of the Most Influential Women in Business of 2021

Genoa Ventures Founder and Managing Partner, Jenny Rooke, has been honored by the San Francisco Business Times as one of the Most Influential Women in Bay Area Business of 2021.

Genoa NewsGuest UserOctober 8, 2021